Payden & Rygel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$62.4M |
| 2 |
Broadcom
AVGO
|
+$44.1M |
| 3 |
General Dynamics
GD
|
+$36M |
| 4 |
Phillips 66
PSX
|
+$33.7M |
| 5 |
Qualcomm
QCOM
|
+$32.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$36.3M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$33.5M |
| 3 |
American Electric Power
AEP
|
+$30.3M |
| 4 |
American Tower
AMT
|
+$29.3M |
| 5 |
Eaton
ETN
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.46% |
| 2 | Healthcare | 15.68% |
| 3 | Technology | 15.42% |
| 4 | Energy | 10.94% |
| 5 | Industrials | 8.58% |
Similar funds
Payden & Rygel's Q1 2022 Portfolio in Review
As of Q1 2022, Payden & Rygel held 143 positions worth $1.98B, down 8.4% from $2.16B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Payden & Rygel withdrew a net $169M in Q1 2022, closing 15 positions and reducing 44 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $33.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Payden & Rygel opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $60.5M.
- Payden & Rygel's largest Q1 2022 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 500,500 shares worth $60.5M.
- Payden & Rygel added most to Broadcom in Q1 2022, an estimated $44.1M increase.
- Payden & Rygel's biggest Q1 2022 reduction was Visa, cutting an estimated $36.3M.
- Payden & Rygel fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2022, selling an estimated $33.5M.
- Payden & Rygel's ten largest holdings make up 24% of its $1.98B portfolio in Q1 2022.
- Payden & Rygel opened 17 new positions and closed 15 in Q1 2022.
- Payden & Rygel's portfolio value fell 8.4% quarter-over-quarter to $1.98B.
Based on Payden & Rygel's 13F filing for Q1 2022, filed 13 Apr 2022.